Variant report
Variant | nsv962275 |
---|---|
Chromosome Location | chr17:18272529-18471923 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1594)
- CpG islands (count:2197)
- Chromatin interactive region (count:19)
- LncRNA region (count:90)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr17:18283094-18283294 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr17:18467518-18467720 | HepG2 | liver: | n/a | n/a |
3 | ATF2 | chr17:18274795-18275169 | GM12878 | blood: | n/a | n/a |
4 | ATF2 | chr17:18314118-18314356 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | ATF3 | chr17:18276575-18276810 | K562 | blood: | n/a | n/a |
6 | BACH1 | chr17:18362390-18362672 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | BACH1 | chr17:18355389-18355575 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | BATF | chr17:18306799-18307466 | GM12878 | blood: | n/a | n/a |
9 | BATF | chr17:18275512-18275864 | GM12878 | blood: | n/a | chr17:18275675-18275686 |
10 | BATF | chr17:18411051-18411300 | GM12878 | blood: | n/a | chr17:18411156-18411166 chr17:18411155-18411166 |
11 | BATF | chr17:18396259-18396664 | GM12878 | blood: | n/a | chr17:18396479-18396490 |
12 | BATF | chr17:18306836-18307314 | GM12878 | blood: | n/a | n/a |
13 | BATF | chr17:18379787-18380078 | GM12878 | blood: | n/a | n/a |
14 | BATF | chr17:18301531-18301764 | GM12878 | blood: | n/a | n/a |
15 | BATF | chr17:18274867-18275146 | GM12878 | blood: | n/a | chr17:18275033-18275043 chr17:18275032-18275043 |
16 | BATF | chr17:18467472-18467685 | GM12878 | blood: | n/a | n/a |
17 | BATF | chr17:18379801-18380128 | GM12878 | blood: | n/a | n/a |
18 | BATF | chr17:18275456-18275836 | GM12878 | blood: | n/a | chr17:18275675-18275686 |
19 | BATF | chr17:18410950-18411370 | GM12878 | blood: | n/a | chr17:18411156-18411166 chr17:18411155-18411166 |
20 | BATF | chr17:18396335-18396562 | GM12878 | blood: | n/a | chr17:18396479-18396490 |
21 | BATF | chr17:18274788-18275214 | GM12878 | blood: | n/a | chr17:18275033-18275043 chr17:18275032-18275043 |
22 | BATF | chr17:18276575-18276822 | GM12878 | blood: | n/a | chr17:18276707-18276718 |
23 | BCL11A | chr17:18379825-18380074 | GM12878 | blood: | n/a | n/a |
24 | BCL11A | chr17:18274726-18275205 | GM12878 | blood: | n/a | n/a |
25 | BCL11A | chr17:18306873-18307246 | GM12878 | blood: | n/a | n/a |
26 | BCL11A | chr17:18275533-18275826 | GM12878 | blood: | n/a | n/a |
27 | BCL11A | chr17:18378052-18378384 | GM12878 | blood: | n/a | n/a |
28 | BCL11A | chr17:18379766-18380162 | GM12878 | blood: | n/a | n/a |
29 | BCL11A | chr17:18306911-18307191 | GM12878 | blood: | n/a | n/a |
30 | BCL11A | chr17:18275505-18275827 | GM12878 | blood: | n/a | n/a |
31 | BCL11A | chr17:18424410-18424651 | GM12878 | blood: | n/a | n/a |
32 | BCL11A | chr17:18274751-18275183 | GM12878 | blood: | n/a | n/a |
33 | BCL3 | chr17:18314773-18315245 | A549 | lung: | n/a | n/a |
34 | BHLHE40 | chr17:18396537-18396565 | K562 | blood: | n/a | n/a |
35 | BHLHE40 | chr17:18280957-18281131 | GM12878 | blood: | n/a | n/a |
36 | BHLHE40 | chr17:18284936-18285074 | K562 | blood: | n/a | n/a |
37 | BHLHE40 | chr17:18466647-18467016 | K562 | blood: | n/a | n/a |
38 | BHLHE40 | chr17:18274727-18275148 | GM12878 | blood: | n/a | n/a |
39 | BHLHE40 | chr17:18277362-18277445 | K562 | blood: | n/a | n/a |
40 | BHLHE40 | chr17:18282904-18283115 | K562 | blood: | n/a | n/a |
41 | BHLHE40 | chr17:18424672-18424862 | GM12878 | blood: | n/a | n/a |
42 | BRCA1 | chr17:18280767-18281046 | Hela-S3 | cervix: | n/a | n/a |
43 | BRCA1 | chr17:18281434-18281557 | Hela-S3 | cervix: | n/a | n/a |
44 | CEBPB | chr17:18317946-18318165 | IMR90 | lung: | n/a | chr17:18318100-18318113 chr17:18318102-18318113 chr17:18318102-18318111 |
45 | CEBPB | chr17:18318052-18318134 | A549 | lung: | n/a | chr17:18318100-18318113 chr17:18318102-18318113 chr17:18318102-18318111 |
46 | CEBPB | chr17:18280775-18281332 | HepG2 | liver: | n/a | chr17:18280955-18280966 |
47 | CEBPB | chr17:18280654-18281216 | MCF-7 | breast: | n/a | chr17:18280955-18280966 |
48 | CEBPB | chr17:18272355-18272702 | Hela-S3 | cervix: | n/a | n/a |
49 | CEBPB | chr17:18467442-18467753 | Hela-S3 | cervix: | n/a | n/a |
50 | CEBPB | chr17:18467487-18467735 | A549 | lung: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:18280183-18280233 | AG10803 | skin: | n/a |
2 | chr17:18280183-18280233 | AG10803 | skin: | n/a |
3 | chr17:18280849-18280899 | HEK293 | kidney: | embryo |
4 | chr17:18287814-18287864 | HMEC | breast: | n/a |
5 | chr17:18305305-18305355 | GM12891 | blood: | n/a |
6 | chr17:18280011-18280061 | NHBE | bronchial: | n/a |
7 | chr17:18431043-18431093 | HNPCEpiC | eye: | n/a |
8 | chr17:18280011-18280061 | SK-N-MC | brain: | n/a |
9 | chr17:18324790-18324840 | AG04450 | lung: | fetal |
10 | chr17:18324895-18324945 | BJ | skin: | n/a |
11 | chr17:18379129-18379179 | HEEpiC | esophagus: | n/a |
12 | chr17:18378879-18378929 | Jurkat | blood: | n/a |
13 | chr17:18379129-18379179 | SK-N-SH_RA | brain: | n/a |
14 | chr17:18283678-18283728 | MCF-7 | breast: | n/a |
15 | chr17:18380354-18380404 | NH-A | brain: | n/a |
16 | chr17:18324895-18324945 | ovcar-3 | ovarian: | n/a |
17 | chr17:18287814-18287864 | HRCEpiC | kidney: | n/a |
18 | chr17:18287814-18287864 | HRPEpiC | eye: | n/a |
19 | chr17:18285838-18285888 | NHDF-neo | bronchial: | n/a |
20 | chr17:18290668-18290718 | RPTEC | kidney: | n/a |
21 | chr17:18286412-18286462 | HCM | heart: | n/a |
22 | chr17:18428092-18428142 | HAEpiC | amniotic membrane: | n/a |
23 | chr17:18285810-18285860 | Hela-S3 | cervix: | n/a |
24 | chr17:18431043-18431093 | Caco-2 | colon: | n/a |
25 | chr17:18285838-18285888 | SKMC | muscle: | n/a |
26 | chr17:18281021-18281071 | Caco-2 | colon: | n/a |
27 | chr17:18419896-18419946 | HIPEpiC | eye: | n/a |
28 | chr17:18285838-18285888 | PANC-1 | pancreas: | n/a |
29 | chr17:18285810-18285860 | SK-N-MC | brain: | n/a |
30 | chr17:18324895-18324945 | HRPEpiC | eye: | n/a |
31 | chr17:18283586-18283636 | SK-N-MC | brain: | n/a |
32 | chr17:18325001-18325051 | HRPEpiC | eye: | n/a |
33 | chr17:18380159-18380209 | ProgFib | skin: | n/a |
34 | chr17:18313121-18313171 | BJ | skin: | n/a |
35 | chr17:18431043-18431093 | RPTEC | kidney: | n/a |
36 | chr17:18287814-18287864 | NT2-D1 | testis: | n/a |
37 | chr17:18313048-18313098 | PrEC | prostate: | n/a |
38 | chr17:18325001-18325051 | HIPEpiC | eye: | n/a |
39 | chr17:18397849-18397899 | LNCaP | prostate: | n/a |
40 | chr17:18305305-18305355 | HRE | kidney: | n/a |
41 | chr17:18429951-18430001 | CMK | blood: | n/a |
42 | chr17:18325001-18325051 | HUVEC | blood vessel: | n/a |
43 | chr17:18428092-18428142 | HIPEpiC | eye: | n/a |
44 | chr17:18281021-18281071 | PFSK-1 | brain: | n/a |
45 | chr17:18286412-18286462 | HRCEpiC | kidney: | n/a |
46 | chr17:18302510-18302560 | SAEC | small airway: | n/a |
47 | chr17:18285838-18285888 | HepG2 | liver: | n/a |
48 | chr17:18286644-18286694 | SKMC | muscle: | n/a |
49 | chr17:18285838-18285888 | H1-hESC | embryonic stem cell: | embryo |
50 | chr17:18429951-18430001 | NHDF-neo | bronchial: | n/a |
(count:19 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:18222850..18223360-chr17:18466465..18467335,2 | MCF-7 | breast: | |
2 | chr17:18271062..18274039-chr17:18283398..18285584,2 | MCF-7 | breast: | |
3 | chr17:18289123..18291183-chr17:20462480..20465308,2 | MCF-7 | breast: | |
4 | chr17:18278481..18280376-chr17:18284493..18286607,2 | K562 | blood: | |
5 | chr13:111365369..111366036-chr17:18280882..18281427,2 | Hela-S3 | cervix: | |
6 | chr17:18266644..18269551-chr17:18275910..18277412,2 | K562 | blood: | |
7 | chr17:18271062..18274039-chr17:18283398..18285584,2 | MCF-7 | breast: | |
8 | chr17:18278481..18280376-chr17:18284493..18286607,2 | K562 | blood: | |
9 | chr17:18273227..18274953-chr17:18289917..18291736,2 | K562 | blood: | |
10 | chr17:18273227..18274953-chr17:18289917..18291736,2 | K562 | blood: | |
11 | chr17:18271239..18274758-chr17:18277396..18280809,3 | MCF-7 | breast: | |
12 | chr17:18272997..18276591-chr17:18278173..18282382,3 | MCF-7 | breast: | |
13 | chr17:18160932..18162896-chr17:18279447..18281125,2 | MCF-7 | breast: | |
14 | chr17:18267096..18271121-chr17:18271318..18274892,4 | K562 | blood: | |
15 | chr17:18274257..18276063-chr17:18279560..18281416,2 | K562 | blood: | |
16 | chr17:18218839..18221214-chr17:18276166..18278374,2 | MCF-7 | breast: | |
17 | chr17:18269319..18271121-chr17:18273220..18274892,2 | K562 | blood: | |
18 | chr17:18271239..18274758-chr17:18277396..18280809,3 | MCF-7 | breast: | |
19 | chr17:18266722..18268365-chr17:18275980..18278903,2 | MCF-7 | breast: |
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
2 | lnc-FAM106A-2 | chr17:18424393-18424459 | ENSG00000273018.1 |
3 | lnc-FAM106A-2 | chr17:18420696-18420787 | ENSG00000273018.1 |
4 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
5 | lnc-FAM106A-2 | chr17:18427091-18427711 | ENSG00000273018.1 |
6 | lnc-FAM106A-2 | chr17:18431887-18432061 | ENSG00000273018.1 |
7 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
8 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
9 | lnc-FAM106A-2 | chr17:18430884-18431074 | ENSG00000273018.1 |
10 | lnc-FAM106A-2 | chr17:18435820-18435911 | ENSG00000273018.1 |
11 | lnc-FAM106A-2 | chr17:18445402-18445501 | ENSG00000273018.1 |
12 | lnc-FAM106A-2 | chr17:18427120-18427191 | ENSG00000273018.1 |
13 | lnc-FAM106A-2 | chr17:18435820-18436192 | ENSG00000273018.1 |
14 | lnc-FAM106A-2 | chr17:18445402-18445501 | ENSG00000273018.1 |
15 | lnc-FAM106A-2 | chr17:18431887-18431914 | ENSG00000273018.1 |
16 | lnc-FAM106A-2 | chr17:18431887-18432061 | ENSG00000273018.1 |
17 | lnc-FAM106A-1 | chr17:18427880-18430160 | NR_026809 |
18 | lnc-FAM106A-2 | chr17:18436661-18437376 | ENSG00000273018.1 |
19 | lnc-FAM106A-2 | chr17:18420725-18420787 | ENSG00000273018.1 |
20 | lnc-FAM106A-2 | chr17:18436661-18436705 | ENSG00000273018.1 |
21 | lnc-FAM106A-2 | chr17:18436661-18436852 | ENSG00000273018.1 |
22 | lnc-FAM106A-2 | chr17:18431887-18432126 | NONHSAT146381 |
23 | lnc-FAM106A-2 | chr17:18427457-18427714 | ENSG00000273018.1 |
24 | lnc-FAM106A-2 | chr17:18420696-18420787 | ENSG00000273018.1 |
25 | lnc-FAM106A-2 | chr17:18444241-18444550 | ENSG00000273018.1 |
26 | lnc-FAM106A-2 | chr17:18446183-18446301 | ENSG00000273018.1 |
27 | lnc-AL353997.5.1-5 | chr17:18380114-18380207 | NONHSAT146376 |
28 | lnc-FAM106A-2 | chr17:18446987-18447029 | ENSG00000273018.1 |
29 | lnc-AL353997.5.1-6 | chr17:18395483-18395859 | NONHSAT146378 |
30 | lnc-FAM106A-2 | chr17:18435820-18435911 | ENSG00000273018.1 |
31 | lnc-FAM106A-2 | chr17:18427091-18427191 | ENSG00000273018.1 |
32 | lnc-AL353997.5.1-2 | chr17:18315660-18315823 | XLOC_012131 |
33 | lnc-AL353997.5.1-1 | chr17:18328108-18328411 | ENSG00000205266.5 |
34 | lnc-FAM106A-2 | chr17:18435820-18435911 | ENSG00000273018.1 |
35 | lnc-FAM106A-2 | chr17:18426379-18426609 | NONHSAT146382 |
36 | lnc-AL353997.5.1-4 | chr17:18343740-18343831 | NONHSAT146373 |
37 | lnc-FAM106A-2 | chr17:18435820-18435911 | ENSG00000273018.1 |
38 | lnc-FAM106A-2 | chr17:18431887-18432061 | ENSG00000273018.1 |
39 | lnc-FAM106A-2 | chr17:18431887-18432298 | ENSG00000273018.1 |
40 | lnc-FAM106A-2 | chr17:18435820-18435911 | ENSG00000273018.1 |
41 | lnc-FAM106A-2 | chr17:18431887-18432061 | ENSG00000273018.1 |
42 | lnc-AL353997.5.1-4 | chr17:18344268-18344334 | NONHSAT146373 |
43 | lnc-FAM106A-2 | chr17:18427091-18427191 | ENSG00000273018.1 |
44 | lnc-AL353997.5.1-5 | chr17:18387189-18387649 | NONHSAT146376 |
45 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
46 | lnc-FAM106A-2 | chr17:18422796-18422988 | ENSG00000273018.1 |
47 | lnc-AL353997.5.1-6 | chr17:18395939-18396053 | NONHSAT146378 |
48 | lnc-FAM106A-2 | chr17:18454820-18454999 | ENSG00000273018.1 |
49 | lnc-FAM106A-2 | chr17:18422796-18422988 | NONHSAT146381 |
50 | lnc-AL353997.5.1-2 | chr17:18315789-18316112 | XLOC_012131 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000205266 | TF binding region |
USP32P2 | TF binding region |
ENSG00000267492 | TF binding region |
KRT16P1 | TF binding region |
ENSG00000267441 | TF binding region |
YWHAEP2 | TF binding region |
EVPLL | TF binding region |
KRT17P2 | TF binding region |
SRP68P2 | TF binding region |
NOS2P2 | TF binding region |
TBC1D3P4 | TF binding region |
ENSG00000264177 | TF binding region |
KRT16P4 | TF binding region |
LGALS9C | TF binding region |
ENSG00000227919 | TF binding region |
TNPO1P2 | TF binding region |
ENSG00000240279 | TF binding region |
ENSG00000227077 | TF binding region |
FAM106A | TF binding region |
ENSG00000220161 | TF binding region |
CCDC144B | TF binding region |
ENSG00000273018 | TF binding region |
ENSG00000205266 | CpG island |
USP32P2 | CpG island |
ENSG00000267492 | CpG island |
KRT16P1 | CpG island |
ENSG00000267441 | CpG island |
YWHAEP2 | CpG island |
EVPLL | CpG island |
KRT17P2 | CpG island |
SRP68P2 | CpG island |
NOS2P2 | CpG island |
TBC1D3P4 | CpG island |
ENSG00000264177 | CpG island |
KRT16P4 | CpG island |
LGALS9C | CpG island |
ENSG00000227919 | CpG island |
TNPO1P2 | CpG island |
ENSG00000240279 | CpG island |
ENSG00000227077 | CpG island |
FAM106A | CpG island |
ENSG00000220161 | CpG island |
CCDC144B | CpG island |
ENSG00000273018 | CpG island |
ENSG00000214860 | chromatin interactions |
ENSG00000153487 | chromatin interactions |
ENSG00000176974 | chromatin interactions |
ENSG00000263946 | chromatin interactions |
ENSG00000177731 | chromatin interactions |
ENSG00000134905 | chromatin interactions |
KIAA0664 | miRNA target sites |
KIAA0528 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567861350 | chr17:18272551-18272552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536982977 | chr17:18272555-18272556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566514886 | chr17:18272595-18272596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374558033 | chr17:18272606-18272607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191066443 | chr17:18272607-18272608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576401741 | chr17:18272642-18272643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183210981 | chr17:18272643-18272644 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559101253 | chr17:18272670-18272671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572609388 | chr17:18272692-18272693 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541222905 | chr17:18272701-18272702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568938565 | chr17:18272708-18272709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561162381 | chr17:18272725-18272726 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113927616 | chr17:18272726-18272727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
14 | rs543715458 | chr17:18272746-18272747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563108838 | chr17:18272762-18272763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541572979 | chr17:18272766-18272767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532136340 | chr17:18272792-18272793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11657395 | chr17:18272800-18272801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62074169 | chr17:18272818-18272819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113499940 | chr17:18272856-18272857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527901527 | chr17:18272866-18272867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548076554 | chr17:18272891-18272892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113215893 | chr17:18272927-18272928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528219302 | chr17:18272947-18272948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547566019 | chr17:18272977-18272978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567885408 | chr17:18273005-18273006 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs533695260 | chr17:18273028-18273029 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs550474756 | chr17:18273047-18273048 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs554641894 | chr17:18273050-18273051 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs569908409 | chr17:18273139-18273140 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs539023123 | chr17:18273153-18273154 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs550195571 | chr17:18273167-18273168 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs116076546 | chr17:18273171-18273172 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs569991414 | chr17:18273191-18273192 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs187872900 | chr17:18273236-18273237 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs535156473 | chr17:18273308-18273309 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs190786913 | chr17:18273361-18273362 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs139319135 | chr17:18273462-18273463 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs150017703 | chr17:18273494-18273495 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs779536 | chr17:18273514-18273515 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs810490 | chr17:18273544-18273545 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs543304944 | chr17:18273558-18273559 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs372902564 | chr17:18273560-18273561 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs183588961 | chr17:18273580-18273581 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs576170270 | chr17:18273645-18273646 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs576767849 | chr17:18273651-18273652 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs57603936 | chr17:18273654-18273655 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs113060859 | chr17:18273664-18273665 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs376143785 | chr17:18273677-18273678 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs531505043 | chr17:18273679-18273680 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Autism | 22543975 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:18267200-18274600 | Weak transcription | NHEK | skin |
2 | chr17:18267200-18288200 | Weak transcription | Right Atrium | heart |
3 | chr17:18267400-18274600 | Weak transcription | Hela-S3 | cervix |
4 | chr17:18267400-18277400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr17:18267600-18274800 | Weak transcription | K562 | blood |
6 | chr17:18271800-18273800 | Enhancers | Placenta | Placenta |
7 | chr17:18272200-18272600 | Enhancers | A549 | lung |
8 | chr17:18272200-18272800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr17:18272600-18274600 | Weak transcription | A549 | lung |
10 | chr17:18273800-18276000 | Weak transcription | Placenta | Placenta |
11 | chr17:18274400-18275000 | Enhancers | Liver | Liver |
12 | chr17:18274600-18275000 | Enhancers | NHEK | skin |
13 | chr17:18274600-18275200 | Enhancers | A549 | lung |
14 | chr17:18274600-18275400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr17:18274600-18275800 | Enhancers | Hela-S3 | cervix |
16 | chr17:18274600-18276600 | Enhancers | GM12878-XiMat | blood |
17 | chr17:18274800-18275000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr17:18274800-18275000 | Bivalent Enhancer | NHLF | lung |
19 | chr17:18274800-18275200 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
20 | chr17:18274800-18275200 | Enhancers | K562 | blood |
21 | chr17:18275000-18280200 | Weak transcription | NHEK | skin |
22 | chr17:18275200-18277400 | Weak transcription | A549 | lung |
23 | chr17:18275800-18277200 | Weak transcription | Hela-S3 | cervix |
24 | chr17:18276000-18276600 | Enhancers | Placenta | Placenta |
25 | chr17:18276600-18277400 | Weak transcription | Placenta | Placenta |
26 | chr17:18277200-18277800 | Enhancers | Hela-S3 | cervix |
27 | chr17:18277400-18277600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
28 | chr17:18277400-18277600 | Enhancers | Placenta | Placenta |
29 | chr17:18277400-18277800 | Enhancers | A549 | lung |
30 | chr17:18277800-18280600 | Weak transcription | Hela-S3 | cervix |
31 | chr17:18277800-18281000 | Weak transcription | A549 | lung |
32 | chr17:18278400-18278800 | Weak transcription | Thymus | Thymus |
33 | chr17:18278800-18279000 | ZNF genes & repeats | Thymus | Thymus |
34 | chr17:18279000-18280600 | Weak transcription | Thymus | Thymus |
35 | chr17:18279800-18280600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
36 | chr17:18279800-18281400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
37 | chr17:18279800-18281400 | Enhancers | Spleen | Spleen |
38 | chr17:18279800-18281800 | Enhancers | Primary monocytes fromperipheralblood | blood |
39 | chr17:18280200-18281000 | Enhancers | NHEK | skin |
40 | chr17:18280400-18280600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
41 | chr17:18280400-18280600 | Enhancers | HepG2 | liver |
42 | chr17:18280400-18281600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
43 | chr17:18280400-18281600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
44 | chr17:18280400-18284200 | Enhancers | Stomach Mucosa | stomach |
45 | chr17:18280600-18280800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
46 | chr17:18280600-18280800 | Flanking Active TSS | Hela-S3 | cervix |
47 | chr17:18280600-18281000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
48 | chr17:18280600-18281200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
49 | chr17:18280600-18281200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
50 | chr17:18280600-18281200 | Flanking Active TSS | HepG2 | liver |